BDO Wealth Advisors’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
Other funds holding VYNE
DA
PA
GCP
VF
BDO Wealth Advisors's VYNE Position: Q4 2021 in Review
BDO Wealth Advisors sold out of VYNE Therapeutics (VYNE) in Q4 2021, closing a stake of 278 shares — an estimated $7K sold.
BDO Wealth Advisors first reported a position in VYNE in Q3 2020 and held it in 5 quarters. The position peaked at $34K in Q1 2021. 54 funds tracked by Wall St. Rank hold VYNE as of Q4 2021.
- BDO Wealth Advisors reported no remaining VYNE Therapeutics position as of Q4 2021 after selling out during the quarter.
- BDO Wealth Advisors sold 278 VYNE Therapeutics shares in Q4 2021, an estimated $7K.
- BDO Wealth Advisors first reported a position in VYNE Therapeutics in Q3 2020 and held it in 5 quarters.
- BDO Wealth Advisors's VYNE Therapeutics position peaked at $34K in Q1 2021.
- 54 funds tracked by Wall St. Rank held VYNE Therapeutics as of Q4 2021.
Based on BDO Wealth Advisors's 13F filing for Q4 2021, filed 11 Feb 2022.